story of the week
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With ER+/ERBB2− Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial
JAMA Oncol 2023 Jul 13;[EPub Ahead of Print], E Munzone, MM Regan, S Cinieri, E Montagna, L Orlando, R Shi, E Campadelli, L Gianni, M Palleschi, F Petrelli, C Bengala, D Generali, E Collovà, F Puglisi, E Cretella, C Zamagni, C Chini, B Ruepp, S Loi, M ColleoniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.